Authors have found that treating ATM-null cells with pro-oxidants reduced the binding of NF-E2 p45-related factor-2 to antioxidant response elements, resulting in decreased expression of target genes compared to ATM-wild type CLL [134]. This evidence concerns the gene ATM and B-cell chronic lymphocytic leukemia.